Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BLEOMYCIN Cause Diffuse large b-cell lymphoma? 13 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Diffuse large b-cell lymphoma have been filed in association with BLEOMYCIN (Bleomycin). This represents 0.2% of all adverse event reports for BLEOMYCIN.

13
Reports of Diffuse large b-cell lymphoma with BLEOMYCIN
0.2%
of all BLEOMYCIN reports
4
Deaths
2
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma From BLEOMYCIN?

Of the 13 reports, 4 (30.8%) resulted in death, 2 (15.4%) required hospitalization.

Is Diffuse large b-cell lymphoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BLEOMYCIN. However, 13 reports have been filed with the FAERS database.

What Other Side Effects Does BLEOMYCIN Cause?

Off label use (656) Febrile neutropenia (632) Neutropenia (433) Drug ineffective (395) Pyrexia (291) Product use in unapproved indication (280) Pulmonary toxicity (263) Thrombocytopenia (260) Nausea (255) Anaemia (252)

What Other Drugs Cause Diffuse large b-cell lymphoma?

RITUXIMAB (1,571) CYCLOPHOSPHAMIDE (1,183) PREDNISONE (1,062) METHOTREXATE (1,055) VINCRISTINE (1,043) DOXORUBICIN (1,002) LENALIDOMIDE (779) TACROLIMUS (595) DEXAMETHASONE (539) PREDNISOLONE (506)

Which BLEOMYCIN Alternatives Have Lower Diffuse large b-cell lymphoma Risk?

BLEOMYCIN vs BLINATUMOMAB BLEOMYCIN vs BLONANSERIN BLEOMYCIN vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 BLEOMYCIN vs BOCEPREVIR BLEOMYCIN vs BOCOCIZUMAB

Related Pages

BLEOMYCIN Full Profile All Diffuse large b-cell lymphoma Reports All Drugs Causing Diffuse large b-cell lymphoma BLEOMYCIN Demographics